Coronavirus (COVID-19) Preparedness Information Learn More
Monoclonal Antibody Treatment
UP Health System - Portage is proud to offer monoclonal antibody therapy to help treat eligible positive COVID-19 patients. Monoclonal antibody therapy helps treat non-hospitalized patients with a mild or moderate case of COVID-19.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. This therapy is designed to help block the COVID-19 virus and prevent the virus from further infecting healthy cells. Patients receiving treatment at our hospital will be required to stay for up to 2 hours: 20-50 minutes for treatment followed by a 1-hour observation.
“Offering this treatment locally is an important step forward in helping prevent the most at-risk patients from being hospitalized due to COVID-19," said Keith Wright, DO, Internal Medicine.
Who is a candidate for monoclonal antibody treatment?
Patients must meet specific clinical criteria, including:
- Lab-confirmed COVID-19 positive test
- Underlying health conditions or over the age of 50
- Stable enough to not require hospitalization
- Be within 10 days of symptom onset
- Certain patients with a specific risk profile may qualify for treatment after exposure to a COVID-19-positive patient before testing postive themselves.
Talk with your provider to see if this treatment is right for you. A physician's referral is required.
Who is not a candidate for this treatment?
This treatment will not be considered for patients who are currently hospitalized due to COVID-19, require oxygen therapy for COVID-19, and/or have a known hypersensitivity to the therapy.
For additional information on treatment for COVID-19 at UP Health System - Portage, please call 906.483.1574.